Lifeboat Foundation

Pterostilbene showing some interesting potential for treating cancer.

One of the most common forms of cancer in the hematologic system is Multiple myeloma (MM) which affects plasma cells, a type of white blood cell that produces antibodies. With advanced symptoms bone pain, bleeding, frequent infections, and anemia may occur.

In studies, Pterostilbene has shown anti-inflammatory and anticarcinogenic properties which has led to the improved function of healthy cells and the inhibition of malignant cells. So far its anticarcinogenic action has been reported for lung, breast and prostate cancers. Today we will look at the latest research showing how it could be used to treat cancer patients.

Continue reading “Pterostilbene an anticarcinogenic breakthrough” »

Microsoft’s cofounder vows to change the “supply side” for breakthrough energy technologies by investing billions of his and his friends’ dollars.

What does the New Year have in store for #CRISPR? This blog presents 5 CRISPR-enabled breakthroughs to look for in 2017. (Partner content via Synthego)

Orcs? 😁

The breakthrough could one day lead to farm-grown organ transplants.

DURHAM, N.C. — Mechanical engineers at Duke University have demonstrated a tiny whirlpool that can concentrate nanoparticles using nothing but sound. The innovation could gather proteins and other biological structures from blood, urine or saliva samples for future diagnostic devices.

Early diagnosis is key to successfully treating many diseases, but spotting early indicators of a problem is often challenging. To pick out the first warning signs, physicians usually must concentrate scarce proteins, antibodies or other biomarkers from small samples of a patient’s body fluid to provide enough of a signal for detection.

While there are many ways to accomplish this today, most are expensive, time-consuming or too cumbersome to take to the field, and they might require trained experts. Duke engineers are moving to develop a new device that addresses these obstacles.

Sharing in case anyone is interested in attending.

What do the Walkie-Talkie, IMAX, the egg carton, instant mashed potatoes and the sport of hockey all have in common? They were all Canadian inventions! You can celebrate Canada’s innovative past, present and future for our country’s 150th anniversary when the Innovation150 National Tour launches at Science World next week. Innovation150 Kick Off at Science World The cross-country Innovation150 tour will celebrate Canadian ingenuity and inspire the innovators of tomorrow. Locally, from January 19 to February 3, 2017, Science World and Innovation150 are organizing a city-wide celebration of Canada’s innovative past, present and future for our country’s 150th anniversary. Innovation.

Experts warn that a potential IVF breakthrough could have unintended social consequences.

Luv my liquid metals and liquid circuits technology.

The U.S. Patent and Trademark Office officially published a series of 55 newly granted patents for Apple Inc. today. In this particular report we cover Apple’s granted patent relating to bulk-solidifying amorphous alloys which is also known for marketing purposes, liquid metal. One tiny aspect of this patent covers how liquid metal can be applied to Apple Products to set their embossed logo as noted in our cover graphic.

Granted Patent: Rapid Discharge Forming Process for Amorphous Metal (Liquid Metal)

Continue reading “Apple Granted Liquid Metal Related Patent for Embossed Apple Logo on Products” »

Nice breakthrough.

A self-adjusting synthetic gene circuit senses and reverses insulin resistance in animal models of diabetes and obesity.

People with type 2 diabetes — an obesity-associated disease that is a major cause of morbidity and mortality worldwide — develop insulin resistance. The condition can be counteracted by adiponectin, a cytokine secreted by adipocytes that promotes insulin sensitivity and regulates glucose metabolism via the receptors AdipoR1 and AdipoR2 (ref.). In fact, by mimicking adiponectin, the AdipoR-activating small molecule AdipoRon improves glucose and lipid metabolism in mice. Owing to the capacity of adipocytes to regulate insulin and glucose pathways, considerable efforts have been devoted to taking advantage of adiponectin for clinical applications. Writing in Nature Biomedical Engineering, Martin Fussenegger and colleagues demonstrate the therapeutic benefits of a self-adjusting synthetic gene circuit designed to sense and reverse insulin resistance in animal models of diabetes and obesity.